Microsomal epoxide hydrolase polymorphisms, cigarette smoking, and risk of colorectal cancer: The Fukuoka Colorectal Cancer Study
β Scribed by Hoirun Nisa; Sanjeev Budhathoki; Makiko Morita; Kengo Toyomura; Jun Nagano; Keizo Ohnaka; Suminori Kono; Takashi Ueki; Masao Tanaka; Yoshihiro Kakeji; Yoshihiko Maehara; Takeshi Okamura; Koji Ikejiri; Kitaroh Futami; Takafumi Maekawa; Yohichi Yasunami; Kenji Takenaka; Hitoshi Ichimiya; Reiji Terasaka
- Book ID
- 112142408
- Publisher
- John Wiley and Sons
- Year
- 2012
- Tongue
- English
- Weight
- 89 KB
- Volume
- 52
- Category
- Article
- ISSN
- 0899-1987
- DOI
- 10.1002/mc.21897
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Microsomal epoxide hydrolase (mEH) and cytochrome P450 2C9 (CYP2C9) are involved in the bioactivation and detoxification of polycyclic aromatic hydrocarbons (PAHs) derived from tobacco smoke. Two codingβregion __mEH__ variants (Tyr113His, His139Arg) and __CYP2C9__ variants (Arg144Cys, I
## Abstract Epidemiological studies have consistently found a positive association between cigarette smoking and risk of colorectal adenomas, so the absence of a clear association between smoking and colorectal cancer risk may seem paradoxical. However, if colorectal cancer develops only after an i